arginine vasopressin has been researched along with pyrrolidonecarboxylic acid in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 8 (42.11) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meck, WH | 1 |
| Costa, E; Del Río, J; Naranjo, JR; Yang, HY | 1 |
| Bolduc, TG; Bruhn, TO; Jackson, IM; Luo, LG; Rondeel, JM | 1 |
| Fahrenholz, F; Gerstberger, R; Jurzak, M | 1 |
| Asakura, W; Hirano, M; Hirate, K; Hiyama, A; Maeda, O; Nakajima, Y | 1 |
| Du, YC; Guo, J; Li, WX; Zhou, AW | 1 |
| Kameyama, T; Nabeshima, T; Narimatsu, H; Nishimura, K; Senzaki, K; Tanaka, T; Yamada, K | 1 |
| Akaike, N; Ohmura, K | 1 |
| Akaike, N; Nabekura, J; Omura, T | 1 |
| Hirate, K; Nishikawa, T; Ohnishi, Y; Sato, T; Tanaka, K; Teramoto, T | 1 |
| Abe, K; Egashira, N; Fujiwara, M; Inada, K; Iwasaki, K; Matsumoto, Y; Mishima, K; Miura, I; Tsukikawa, H | 1 |
| Hirate, K; Irifune, M; Nishikawa, T; Ohnishi, Y; Sato, T; Tanaka, K; Teramoto, T | 1 |
| Chepkova, AN; Gudasheva, TA; Kapai, NA; Morozova, AA; Skrebitskii, VG | 1 |
| Itoh, H; Kurachi, M; Matsuoka, T; Sumiyoshi, T; Tanaka, K; Tsunoda, M; Uehara, T | 1 |
| Jiang, XG; Lu, W; Xie, YL | 1 |
| Hirate, K; Irifune, M; Ishida, T; Nakamura, N; Nishikawa, T; Sato, T; Tanaka, K | 2 |
| Kamei, C; Mikami, A; Shimada, K; Tarumi, T | 1 |
| Lekic, T; Manaenko, A; Tang, J; Zhang, JH | 1 |
1 review(s) available for arginine vasopressin and pyrrolidonecarboxylic acid
| Article | Year |
|---|---|
[The effect of NC-1900: its ameliorating effects on impairments of learning and memory in the CA1 neurons and its intracellular signal transduction pathways].
Topics: Animals; Arginine Vasopressin; Hippocampus; Learning; Memory; Mice; Oligopeptides; Pyramidal Cells; Pyrrolidonecarboxylic Acid; Rats; Signal Transduction | 1998 |
18 other study(ies) available for arginine vasopressin and pyrrolidonecarboxylic acid
| Article | Year |
|---|---|
Vasopressin metabolite neuropeptide facilitates simultaneous temporal processing.
Topics: Animals; Appetitive Behavior; Arginine Vasopressin; Attention; Auditory Perception; Cues; Male; Mental Recall; Neuropeptides; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Reinforcement Schedule; Time Perception; Touch; Visual Perception | 1987 |
Substance P-induced release of Met5-enkephalin from striatal and periaqueductal gray slices.
Topics: Animals; Arginine Vasopressin; Bombesin; Corpus Striatum; Dose-Response Relationship, Drug; Enkephalin, Methionine; Male; Naloxone; Neurotensin; Nociceptors; Peptide Fragments; Periaqueductal Gray; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Sensory Thresholds; Substance P | 1983 |
Activation of thyrotropin-releasing hormone gene expression in cultured fetal diencephalic neurons by differentiating agents.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Arginine Vasopressin; Bromodeoxyuridine; Cells, Cultured; Colforsin; Diencephalon; Female; Fetus; Gene Expression Regulation, Developmental; Neurons; Pregnancy; Protein Precursors; Pyrrolidonecarboxylic Acid; Rats; RNA, Messenger; Somatostatin; Thyrotropin-Releasing Hormone | 1996 |
Vasopressin anti-idiotypic antibody staining in the rat brain: colocalization with [35S] [pGlu4, Cyt6]AVP(4-9) binding sites.
Topics: Animals; Antibodies, Monoclonal; Arginine Vasopressin; Autoradiography; Brain; Brain Chemistry; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Immunohistochemistry; Male; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Receptors, Vasopressin; Sulfur Radioisotopes; Vasopressins | 1993 |
No. 302, a newly synthesized [pGlu4,Cyt6]AVP(4-9) analogue, prevents the disruption of avoidance behavior.
Topics: Animals; Arginine Vasopressin; Avoidance Learning; Cycloheximide; Half-Life; Male; Nootropic Agents; Peptide Fragments; Protein Synthesis Inhibitors; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar | 1997 |
Facilitation of AVP(4-8) on gene expression of BDNF and NGF in rat brain.
Topics: Animals; Arginine Vasopressin; Blotting, Northern; Brain; Brain-Derived Neurotrophic Factor; DNA, Complementary; Gene Expression Regulation; In Situ Hybridization; Male; Nerve Growth Factors; Neurotrophin 3; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; RNA, Antisense; RNA, Messenger; Transcription, Genetic | 1997 |
NC-1900, an active fragment analog of arginine vasopressin, improves learning and memory deficits induced by beta-amyloid protein in rats.
Topics: Amyloid beta-Peptides; Animals; Arginine Vasopressin; Behavior, Animal; Choline O-Acetyltransferase; Frontal Lobe; Hippocampus; Injections, Intraventricular; Learning Disabilities; Male; Memory Disorders; Oligopeptides; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar | 1998 |
Intracellular pathways of V(1) and V(2) receptors activated by arginine vasopressin in rat hippocampal neurons.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Colforsin; Cyclic AMP-Dependent Protein Kinases; Deamino Arginine Vasopressin; Egtazic Acid; Enzyme Inhibitors; Glycine; Hippocampus; Neurons; Oligopeptides; Patch-Clamp Techniques; Peptide Fragments; Protein Kinase C; Pyrrolidonecarboxylic Acid; Rats; Receptors, Vasopressin | 1999 |
[The ameliorating effects of a novel NC-1900 on impairments of learning/memory caused by glutamic acid].
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Arginine Vasopressin; Avoidance Learning; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamic Acid; Glycine; Kainic Acid; Learning Disabilities; Male; Memory Disorders; Mice; Mice, Inbred Strains; N-Methylaspartate; Neuromuscular Depolarizing Agents; Oligopeptides; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Resorcinols | 1999 |
Ameliorative effect of NC-1900, a new AVP4-9 analog, through vasopressin V1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium-Calmodulin-Dependent Protein Kinases; Cholinergic Antagonists; Maze Learning; Memory; Microdialysis; Nicardipine; Nootropic Agents; Oligopeptides; Pirenzepine; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Receptors, Vasopressin; Scopolamine | 2003 |
Facilitative effect of a novel AVP fragment analog, NC-1900, on memory retention and recall in mice.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Enzyme Activators; Male; Memory; Mental Recall; Mice; Mice, Inbred Strains; Oligopeptides; Phorbol Esters; Piperidines; Protein Kinase C; Pyrrolidonecarboxylic Acid; Receptors, Vasopressin; Stimulation, Chemical; Tetradecanoylphorbol Acetate | 2004 |
Pyroglutamyl-asparagine amide normalizes long-term potentiation in rat hippocampal slices.
Topics: Animals; Arginine Vasopressin; Dipeptides; Electric Stimulation; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Nootropic Agents; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar | 2004 |
NC-1900, an arginine-vasopressin analogue, ameliorates social behavior deficits and hyperlocomotion in MK-801-treated rats: therapeutic implications for schizophrenia.
Topics: Analysis of Variance; Animals; Arginine Vasopressin; Ataxia; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Hyperkinesis; Male; Motor Activity; Oligopeptides; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Schizophrenia; Social Behavior Disorders; Stereotyped Behavior | 2005 |
Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice.
Topics: Animals; Arginine Vasopressin; Avoidance Learning; Drug Carriers; Drug Delivery Systems; Male; Memory; Memory Disorders; Mice; Nanostructures; Nootropic Agents; Oligopeptides; Particle Size; Peptide Fragments; Polyethylene Glycols; Pyrrolidonecarboxylic Acid; Random Allocation; Scopolamine; Serum Albumin, Bovine | 2006 |
Effect of NC-1900, an active fragment analog of arginine vasopressin, and inhibitors of arachidonic acid metabolism on performance of a passive avoidance task in mice.
Topics: Amnesia; Animals; Arachidonic Acid; Arginine Vasopressin; Avoidance Learning; Cyclooxygenase 2; Enzyme Inhibitors; Injections, Intraperitoneal; Injections, Intraventricular; Male; Memory; Mice; Oligopeptides; Pyrrolidonecarboxylic Acid | 2007 |
Inhibitory effect of cyclooxygenase inhibitors on the step-through passive avoidance performance in mice treated with NC-1900, an arginine-vasopressin fragment analog.
Topics: Animals; Arginine Vasopressin; Avoidance Learning; Behavior, Animal; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Indomethacin; Male; Memory; Mice; Mice, Inbred Strains; Nitrobenzenes; Oligopeptides; Piroxicam; Pyrrolidonecarboxylic Acid; Sulfonamides | 2007 |
Participation of the cholinergic system in ameliorating effect of vasopressin fragment by group I metabotropic glutamate-receptor blockade.
Topics: Animals; Arginine Vasopressin; Behavior, Animal; Cholinergic Fibers; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Hippocampus; Indans; Male; Maze Learning; Mecamylamine; Memory; Muscarinic Antagonists; Nicotinic Antagonists; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Receptors, Muscarinic; Scopolamine | 2008 |
NC1900, an arginine vasopressin analogue, fails to reduce brain edema and improve neurobehavioral deficits in an intracerebral hemorrhagic stroke mice model.
Topics: Analysis of Variance; Animals; Aquaporin 4; Arginine Vasopressin; Basal Ganglia; Brain Edema; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Exploratory Behavior; Functional Laterality; Gait Disorders, Neurologic; Male; Mice; Movement Disorders; Oligopeptides; Pyrrolidonecarboxylic Acid; Time Factors | 2011 |